Indapamide Clinical Trials Indapamide RSS feedThis is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) Cognitive Sub-Study
Conditions:   Cognitive Decline;   Intracerebral Hemorrhage;   Dementia, Vascular;   Cerebral Small Vessel Diseases;   Hypertension;   Stroke Hemorrhagic Interventions:   Drug: telmisartan 20mg + amlodipine 2.5mg +indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 24, 2018 Category: Research Source Type: clinical trials

Triple Therapy Prevention of Recurrent Intracerebral Disease EveNts Trial (TRIDENT) MRI Sub-study
Conditions:   Stroke;   Cerebral Small Vessel Diseases;   Intracerebral Hemorrhage;   Vascular Dementia;   Hypertension Interventions:   Drug: telmisartan 20 mg + amlodipine 2.5mg + indapamide 1.25mg;   Drug: Placebo oral capsule Sponsors:   The George Institute;   University of Sydney Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - December 21, 2018 Category: Research Source Type: clinical trials

Short-term Effects of Perindopril-amlodipine Versus Perindopril-indapamide in Type 2 Diabetes
Conditions:   Diabetes Mellitus, Type 2;   Hypertension Interventions:   Drug: Perindopril and Amlodipine;   Drug: Perindopril-indapamide Sponsors:   Yaounde Central Hospital;   University of Yaounde 1 Completed (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 20, 2018 Category: Research Source Type: clinical trials